デフォルト表紙
市場調査レポート
商品コード
1609905

日本のアニマルヘルス市場レポート:動物タイプ、製品タイプ、地域別、2024年~2032年

Japan Animal Health Market Report by Animal Type (Commercial, Companions), Product Type (Pharmaceuticals, Biologicals, Medicinal Feed Additives, Diagnostics), and Region 2024-2032


出版日
発行
IMARC
ページ情報
英文 115 Pages
納期
5~7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
日本のアニマルヘルス市場レポート:動物タイプ、製品タイプ、地域別、2024年~2032年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 115 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のアニマルヘルス市場の市場規模は2023年に26億9,730万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに49億1,730万米ドルに達し、2024年から2032年の間に6.9%の成長率(CAGR)を示すと予測しています。動物から人へ感染する人獣共通感染症の流行が増加していることと、動物の健康状態を監視・管理することの重要性に対する認識が高まっていることが、主に市場を牽引しています。

本レポートで扱う主な質問

  • 日本のアニマルヘルス市場はこれまでどのように推移し、今後どのように推移していくのか?
  • 日本のアニマルヘルス市場へのCOVID-19の影響は?
  • 日本のアニマルヘルス市場の動物タイプ別の内訳は?
  • 日本のアニマルヘルス市場の製品タイプ別の内訳は?
  • 日本のアニマルヘルス市場のバリューチェーンにはどのような段階がありますか?
  • 日本のアニマルヘルスにおける主な促進要因と課題は何か?
  • 日本のアニマルヘルス市場の構造と主要プレーヤーは?
  • 日本のアニマルヘルス市場における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のアニマルヘルス市場:イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本のアニマルヘルス市場情勢

  • 過去および現在の市場動向(2018~2023年)
  • 市場予測(2024~2032年)

第6章 日本のアニマルヘルス市場:動物タイプ別の内訳

  • 商業
  • コンパニオン

第7章 日本のアニマルヘルス市場:製品タイプ別の内訳

  • 医薬品
  • 生物製剤
  • 医薬品飼料添加物
  • 診断

第8章 日本のアニマルヘルス市場:競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第9章 主要企業のプロファイル

第10章 日本のアニマルヘルス市場:業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第10章 付録

目次
Product Code: SR112024A18013

Japan animal health market size reached US$ 2,697.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 4,917.3 Million by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2024-2032. The increasing prevalence of zoonotic diseases, which can be transmitted from animals to humans, along with the rising awareness about the importance of monitoring and managing the health of animals, is primarily driving the market.

Animal health refers to the overall well-being and physical condition of animals, both domestic and wild. It encompasses various aspects of their health, including their physical, mental, and emotional states. Maintaining good animal health is essential for the welfare of individual animals and the health of ecosystems. Animal health involves the prevention, diagnosis, and treatment of diseases and injuries that can affect animals. This includes providing them with proper nutrition, clean water, shelter, and appropriate veterinary care. Additionally, it encompasses measures to prevent the spread of diseases among animals, which can also impact human health in some cases. Animal health is crucial for various reasons, including the ethical responsibility to treat animals with kindness and respect, the economic importance of livestock and agricultural animals, and the preservation of biodiversity in the wild. Monitoring and promoting animal health are vital for ensuring the sustainability of ecosystems and the well-being of both animals and humans.

Japan Animal Health Market Trends:

The animal health market in Japan is experiencing robust growth due to several interconnected drivers. Firstly, the regional population's increasing awareness of pet and livestock well-being has led to a heightened demand for high-quality veterinary products and services. Furthermore, the rise in disposable income on account of emerging economy has spurred greater spending on companion animal health, driving market expansion. Additionally, zoonotic diseases have gained prominence in recent years, underscoring the importance of disease prevention and control in animals. This has stimulated investment in vaccines, diagnostics, and pharmaceuticals for both pets and livestock as governments and organizations recognize the critical link between animal and human health. Moreover, the ongoing technological advancements, which have enabled the development of innovative products and treatments, like precision medicine, telemedicine, and digital health solutions, are expected to drive the animal health market in Japan during the forecast period.

Japan Animal Health Market Segmentation:

Animal Type Insights:

  • Commercial
  • Companions

Product Type Insights:

  • Pharmaceuticals
  • Biologicals
  • Medicinal Feed Additives
  • Diagnostics

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

  • Ceva Animal Health
  • Elanco Animal Health Incorporated
  • Neogen Corporation
  • Nippon Boehringer Ingelheim Co. Ltd. (Boehringer Ingelheim Auslandsbeteiligungs GmbH)
  • Vetoquinol Japan Co. Ltd.
  • Virbac
  • Zoetis Japan

Key Questions Answered in This Report:

  • How has the Japan animal health market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan animal health market?
  • What is the breakup of the Japan animal health market on the basis of animal type?
  • What is the breakup of the Japan animal health market on the basis of product type?
  • What are the various stages in the value chain of the Japan animal health market?
  • What are the key driving factors and challenges in the Japan animal health?
  • What is the structure of the Japan animal health market and who are the key players?
  • What is the degree of competition in the Japan animal health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Animal Health Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Animal Health Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Animal Health Market - Breakup by Animal Type

  • 6.1 Commercial
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Forecast (2024-2032)
  • 6.2 Companions
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)

7 Japan Animal Health Market - Breakup by Product Type

  • 7.1 Pharmaceuticals
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Biologicals
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Medicinal Feed Additives
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)
  • 7.4 Diagnostics
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2018-2023)
    • 7.4.3 Market Forecast (2024-2032)

8 Japan Animal Health Market - Competitive Landscape

  • 8.1 Overview
  • 8.2 Market Structure
  • 8.3 Market Player Positioning
  • 8.4 Top Winning Strategies
  • 8.5 Competitive Dashboard
  • 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

  • 9.1 Ceva Animal Health
    • 9.1.1 Business Overview
    • 9.1.2 Product Portfolio
    • 9.1.3 Business Strategies
    • 9.1.4 SWOT Analysis
    • 9.1.5 Major News and Events
  • 9.2 Elanco Animal Health Incorporated
    • 9.2.1 Business Overview
    • 9.2.2 Product Portfolio
    • 9.2.3 Business Strategies
    • 9.2.4 SWOT Analysis
    • 9.2.5 Major News and Events
  • 9.3 Neogen Corporation
    • 9.3.1 Business Overview
    • 9.3.2 Product Portfolio
    • 9.3.3 Business Strategies
    • 9.3.4 SWOT Analysis
    • 9.3.5 Major News and Events
  • 9.4 Nippon Boehringer Ingelheim Co. Ltd. (Boehringer Ingelheim Auslandsbeteiligungs GmbH)
    • 9.4.1 Business Overview
    • 9.4.2 Product Portfolio
    • 9.4.3 Business Strategies
    • 9.4.4 SWOT Analysis
    • 9.4.5 Major News and Events
  • 9.5 Vetoquinol Japan Co. Ltd.
    • 9.5.1 Business Overview
    • 9.5.2 Product Portfolio
    • 9.5.3 Business Strategies
    • 9.5.4 SWOT Analysis
    • 9.5.5 Major News and Events
  • 9.6 Virbac
    • 9.6.1 Business Overview
    • 9.6.2 Product Portfolio
    • 9.6.3 Business Strategies
    • 9.6.4 SWOT Analysis
    • 9.6.5 Major News and Events
  • 9.7 Zoetis Japan
    • 9.7.1 Business Overview
    • 9.7.2 Product Portfolio
    • 9.7.3 Business Strategies
    • 9.7.4 SWOT Analysis
    • 9.7.5 Major News and Events

Please note that this is only a partial list of the key players, and the complete list is provided in the report.

10 Japan Animal Health Market - Industry Analysis

  • 10.1 Drivers, Restraints, and Opportunities
    • 10.1.1 Overview
    • 10.1.2 Drivers
    • 10.1.3 Restraints
    • 10.1.4 Opportunities
  • 10.2 Porters Five Forces Analysis
    • 10.2.1 Overview
    • 10.2.2 Bargaining Power of Buyers
    • 10.2.3 Bargaining Power of Suppliers
    • 10.2.4 Degree of Competition
    • 10.2.5 Threat of New Entrants
    • 10.2.6 Threat of Substitutes
  • 10.3 Value Chain Analysis

10 Appendix